Mepitel Film Breast

NCT07729423 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-07-27

No results posted yet for this study

Summary

Primary Objective To examine the tolerability of Mepitel Film in the prevention of RD patients undergoing whole breast or chest wall RT in the hot and humid weather in Singapore

Secondary Objectives To evaluate the incidence of acute radiation dermatitis, quality of life, satisfaction, and cost analysis of Mepitel Film use.

Conditions

Sponsors & Collaborators

  • Molnlycke Health Care AB

    collaborator INDUSTRY
  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Wee Yao Koh, MBBS · National University Hospital, Singapore

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-12
Primary Completion
2028-12-31
Completion
2029-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07729423 on ClinicalTrials.gov